A carregar...

Lomitapide at Supratherapeutic Plasma Levels Does Not Prolong the QTc Interval—Results from a TQT Study with Moxifloxacin and Ketoconazole

BACKGROUND: The aim of this study was to assess the effect of high plasma levels of lomitapide and its main metabolite on ECG parameters. METHODS: In this randomized five‐way cross‐over thorough QT study, 56 healthy subjects were enrolled. Study treatments were administered orally for 3 days in five...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Noninvasive Electrocardiol
Main Authors: Darpo, Borje, Ferber, Georg, Zhou, Meijian, Sumeray, Mark, Sager, Philip
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6932020/
https://ncbi.nlm.nih.gov/pubmed/24118671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/anec.12103
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!